Prof. Ernst has reviewed all the studies. (more…)

Doctors use the word “functional” to describe symptoms or problems when they can find no anatomical abnormality.

Researchers from the University of Texas Medical Branch, in Galveston reviewed the evidence using acupuncture and electro acupuncture. (more…)

Here’s the rationale supporting this study by researchers at the Mayo Clinic, in Rochester, Minnesota.

St. John’s wort treats mild-to-moderate depression. Antidepressants are often used to treat irritable bowel syndrome (IBS). But no one has studied the effects of St. John’s wort in patients with IBS. (more…)

Are chiropractic treatments effective for gastrointestinal disorders?

Prof. Ernst has reviewed the evidence. (more…)

Approximately two-thirds of patients with irritable bowel syndrome (IBS) respond well to hypnotherapy.

Researchers at the University of Manchester, in the UK, assessed whether a therapeutic response to hypnosis could be predicted by relating mood to a positive, neutral or negative color. (more…)

Studies suggest that in one quarter of patients, symptoms of irritable bowel syndrome (IBS) may be caused or exacerbated by diet.

Researchers from the University of North Carolina School of Medicine, at Chapel Hill, reviewed the data from a clinician’s perspective. (more…)

The British Nutrition Foundation reviewed the effect of probiotics on health. (more…)

Researchers from The Beth Israel Deaconess Medical Center, in Boston compared true and sham acupuncture in relieving symptoms of irritable bowel syndrome. (more…)

Several can be recommended as part of an evidence-based approach to treating irritable bowel syndrome (IBS), according to researchers from the University of Ottawa in Ontario. (more…)

Hacked By GeNErAL

Greetz : Kuroi’SH, RxR, K3L0T3X

Hacked By GeNErAL! !

 The American College of Gastroenterology has published new guidelines for the management of irritable bowel syndrome (IBS).

Let’s focus on their view of herbals, acupuncture, and diet. (more…)

An international group of researchers report that peppermint oil is “more effective than placebo in the treatment of irritable bowel syndrome (IBS).”

It compared favorably to fiber and antispasmodic drugs too. (more…)

 NewsWise reports the results of 3 studies presented during the American College of Gastroenterology’s 73rd Annual Scientific Meeting in Orlando.

Highlights of the reports on probiotics used to treat irritable bowel syndrome (IBS) follow. (more…)

 One-third of these patients use CAM.

Are they dissatisfied with mainstream treatments? (more…)

Recently, the use of tegaserod (Zelnorm) and alosetron (Lotronex) to treat irritable bowel syndrome (IBS) was restricted because of adverse events.

Here’s what we know about probiotics for the relief of symptoms of IBS. (more…)

Growing evidence suggests that probiotics might serve as a functional food in the treatment of diarrhea.

Here’s what we know.

(more…)

Dr. Ethan Russo (no relation) is a consultant for GW Pharmaceuticals and a proponent of medical marijuana.

This article is the latest justification that “migraine, fibromyalgia, irritable bowel syndrome, and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines.” (more…)

In general, past entries on this topic were positive, although peppermint oil gets a “C” rating (inconsistent or limited-quality patient-oriented evidence) for irritable bowel syndrome (IBS).

Maybe so, but here is another supportive study that tested the effectiveness of enteric-coated peppermint oil in a well-defined group of patients. (more…)

No consistent, good-quality patient-oriented evidence is available on peppermint oil (Mentha piperita). So, the authors based their conclusions on the criteria in the strength of recommendation taxonomy (SORT). (more…)

Three criteria determine drug reimbursement decisions: therapeutic value, cost effectiveness, and burden of disease. Now, an article from Erasmus University in The Netherlands questions whether it’s sufficient for a drug to meet these criteria, and proposes a 4th hurdle.

Consider how CAM would hold up under such scrutiny based on what we know today. (more…)